Calidi Biotherapeutics

CLDINYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$2.959 M

$1.11 +1.12%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$19.9M

Loss-making

Shares outstanding

2,584,184

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#155VivoSim LabsVIVS$4.12M
#156Silexion TherapeuticsSLXN$3.13M
#157Calidi BiotherapeuticsCLDI$2.96M
#158CurisCRIS$2.04M
#159Tessera Defense & Homeland SecurityHLSQ$1.97M

What if Calidi Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$11,380,331

Per share 10,231,350× higher

Bitcoin $1.72T

$646,492.06

Per share 581,221× higher

Nvidia $5.48T

$2,059,935

Per share 1,851,960× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Calidi Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.